FULT Heads Into Earnings With Shorts Rebuilding and Bulls Calling Timeout

Fulton Financial reports Q3 results on October 22 with short sellers quietly building positions into the print, even as the stock ticks higher and options traders lean decisively to the call side.

The short side has been adding up steadily. Short interest now runs at 5.9% of the free float, having climbed roughly 15% over the past month to reach 10.6 million shares. The pace picked up this week, with shares short rising 4.3% in five sessions. That said, the borrow market is under no meaningful stress. Availability is extremely loose at more than 1,450% of short interest, meaning there are roughly fourteen shares available to borrow for every one currently shorted. Cost to borrow has eased to 0.47%, down 16% on the week, the cheapest level in recent weeks. The ORTEX short score of 47, which has edged up from 45.7 to 47.1 over the past fortnight, reflects this slow build rather than any acute squeeze dynamic. Positioning looks deliberate rather than panicked.

Options traders are telling a different story. The put/call ratio has dropped to 0.13, more than one standard deviation below its 20-day average of 0.15 and close to the 52-week low of 0.07. That is a heavily call-skewed setup, meaning options participants are not paying up for downside protection going into the print. Combined with a 3.1% gain on the week to $22.63, the stock and its options market are pointing in the same direction. Whether the shorts are hedging existing positions or building fresh conviction is the open question, but the cost of being wrong is clearly not worrying the options market.

The Street is cautious without being bearish. The consensus rating is a hold across five analysts, with a mean price target of $26.42, which implies roughly 17% upside from current levels. The most notable recent move came on October 6, when Raymond James downgraded to Market Perform, ending its Outperform stance before earnings. Earlier in August, Piper Sandler reiterated Neutral while lifting its target from $23 to $27. The bull case, as articulated in recent analyst commentary, rests on NIM expansion, a strong credit culture, and scarcity value in a high-demand Mid-Atlantic geography. The bear case centres on the Blue Foundry acquisition overhang, modest organic loan growth, and higher expenses eroding profitability improvements. The P/E has eased to 9.6x and price-to-book to 1.08x, both contracting slightly over the past month as the stock has given back 3.3% on a one-month view. Factor scores put EPS surprise at the 35th percentile and dividend quality at the 72nd, reflecting a bank that rewards income investors more reliably than it beats estimates.

The company's own FDIC call report data adds a straightforward data point ahead of the print. Net loans and leases has risen for five consecutive quarters, reaching $24 billion. Total deposits has grown for four straight quarters, reaching $27.4 billion. No measured leading indicator links this FDIC data to the quarterly net income print yet, as ORTEX notes the series does not yet have enough history to test. The streaks confirm organic balance sheet momentum, but they are not a guide to where the reported numbers land.

Institutional flows show broad-based net buying on recent filings. T. Rowe Price added nearly 4 million shares in the latest reported quarter, taking its stake to 6.1% of shares outstanding. BlackRock added 1.6 million shares to hold 14.7%. State Street and Dimensional both added modestly. None of the five holders on the 13D/G register are activist investors, all filed Schedule 13G disclosures indicating passive intent. Insider activity in the 90-day window is net negative at roughly 21,700 shares sold, though the transactions are almost entirely tax-withholding events tied to option exercises, compensation mechanics rather than conviction selling.

The previous three earnings prints produced first-day moves of minus 1.5%, plus 0.5%, and minus 1.5%, with no print producing a move larger than 2% in either direction on day one. The five-day reaction after October's 2025 print was a positive 2.1%, consistent with initial weakness being absorbed by the broader sector. With the Raymond James downgrade already in the market, the bar for a negative surprise to move the needle further may be lower than usual. What to watch is whether the NIM trajectory and credit quality commentary from management address the Street's specific integration and expense concerns, because the stock has already priced out some of its earlier year optimism.